Browse Related Topics For:

ANDA

199
Pharmaceutical Industry
197
Patents
169
Pharmaceutical Patents
159
Patent Litigation
157
Generic Drugs
148
Patent Infringement
85
FDA
77
Hatch-Waxman
75
Prescription Drugs
40
Mylan Pharmaceuticals
35
Reverse Payment Settlement Agreements
35
SCOTUS
32
FTC
30
FTC v Actavis
29
Actavis Inc.
29
Teva Pharmaceuticals
25
Biotechnology
24
Obviousness
20
Apotex
20
Personal Jurisdiction
19
Merck
19
Patent Invalidity
18
Patent-in-Suit
17
AstraZeneca
15
Infringement
15
Prior Art
14
Claim Construction
14
Eli Lilly
14
Watson Pharmaceuticals
13
Antitrust Litigation
13
Pay-For-Delay
13
Sandoz
12
Novartis
11
Cephalon
11
Jurisdiction
11
Noninfringement
11
Orange Book
10
Declaratory Judgments
10
FDCA
10
Labeling
10
Pfizer
9
DaimlerChrysler v Bauman
9
Motion to Dismiss
9
Par Pharmaceutical
9
Popular
9
USPTO
8
Allergan Inc
8
Appeals
8
BPCIA
8
Inter Partes Review Proceedings
8
Patent Trial and Appeal Board
8
Safe Harbors
8
Sherman Act
7
Biosimilars
7
FDA Approval
7
Generic
7
Healthcare
7
Induced Infringement
7
Roxane Laboratories
7
Specific Jurisdiction
6
Biologics
6
DaimlerAG
6
Janssen Pharmaceuticals
6
Medical Devices
6
Patent Applications
6
Prometheus
6
Written Descriptions
5
Amgen
5
Anti-Competitive
5
Gilead Sciences
5
GlaxoSmithKline
5
Manufacturers
5
Minimum Contacts
5
Orphan Drugs
5
Otsuka Pharmaceutical
5
Rule-of-Reason Analysis
5
Summary Judgment
4
America Invents Act
4
Bayer
4
Boehringer
4
Corporate Counsel
4
General Jurisdiction
4
Hospira
4
Intellectual Property Litigation
4
Life Sciences
4
Medicare
4
No-AG Agreement
4
Patent-Eligible Subject Matter
4
Settlement
4
Warner Chilcott
3
Affordable Care Act
3
Antitrust Provisions
3
Bristol-Myers Squibb
3
Class Action
3
Classen Immunotherapies
3
Disgorgement
3
Doctrine of Equivalents
3
Elan Pharmaceuticals
3
Enablement Inquiries
3
Endo Pharmaceuticals
3
Estoppel
3
Exclusivity
3
Failure To Warn
3
Federal Rule 12(b)(6)
3
Forest Laboratories
3
Forum Shopping
3
Fresenius
3
HHS
3
Jazz Pharmaceuticals
3
Legislative Agendas
3
Medicare Modernization Act
3
RanBaxy
3
Real Party in Interest
3
Spectrum
3
Standing
3
Takeda Pharmaceuticals
3
Unfair Competition
2
AbbVie
2
Allergan v Sandoz
2
Amarin
2
Antitrust Investigations
2
Antitrust Violations
2
Bausch & Lomb
2
Biopharmaceutical
2
Cadence Pharmaceuticals Inc.
2
Cadillac Tax
2
Cancer
2
Certiorari
2
Chevron Deference
2
Citizen Petitions
2
Clinical Trials
2
CLS Bank v Alice Corp
2
CMS
2
Counterclaims
2
De Novo Standard of Review
2
Disclosure Requirements
2
DSCSA
2
Extortion
2
FDA Warning Letters
2
Federal Budget
2
First Amendment
2
Forum
2
Health Care Providers
2
Health Insurance
2
Indefiniteness
2
Injunctions
2
Inter Partes Reexamination
2
Interlocutory Appeals
2
IRS
2
ITC
2
Limelight v Akamai
2
Malicious Prosecution
2
Medicaid
2
Method Claims
2
Motion To Stay
2
New Guidance
2
Obama Administration
2
Off-Label Promotion
2
OIG
2
On-Sale Bar
2
OxyContin
2
Patients
2
Permanent Injunctions
2
Pleading Standards
2
Pleadings
2
PLIVA v Mensing
2
Preemption
2
Preliminary Injunctions
2
Product Hopping
2
Product Labels
2
Proposed Legislation
2
Putative Class Actions
2
Reissue Patents
2
REMS
2
Reversal
2
Reverse Payments
2
Sandoz v Amgen
2
Sanofi-Aventis
2
Subject Matter Jurisdiction
2
Trademarks
2
TRO
2
Vaccinations
1
Abbott Laboratories
1
aBLA
1
ACOs
1
Administrative Procedure Act
1
Advertising
1
AHRQ
1
Amazon
1
Ambiguous
1
Anti-SLAPP
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
App Developers
1
Arbitration
1
Arbitration Agreements
1
Article III
1
Automatic Stay
1
Bifurcation
1
Bipolar Disorder
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
CAFC
1
Cal Code of Civil Procedure
1
Caronia
1
Carve Out Provisions
1
CDC
1
Certifications
1
CGMP
1
CHIP
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Claims Limitations Period
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Laboratory Testing
1
Combination Products
1
Competition
1
Complex Litigation
1
Compliance
1
Consent
1
Consent Order
1
Continuing Resolution
1
Contract Disputes
1
Contract Drafting
1
Copyright
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Damages
1
Data Protection
1
Data Security
1
Debt Ceiling
1
Delaware General Corporation Law
1
Dell
1
Direct Infringement
1
Direct Purchasers
1
Disclosure
1
Discovery
1
Dismissals
1
Dispute Resolution
1
Divided Infringement
1
DOJ
1
Draft Guidance
1
Drug Pricing
1
Due Process
1
Duty to Deal
1
E-Filing
1
Electronic Records
1
Employer Mandates
1
En Banc Review
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Fair Market Value
1
False Claims Act (FCA)
1
FDASIA
1
Federal Jurisdiction
1
Federal Rules of Civil Procedure
1
Foreign Corporations
1
Foreign Defendants
1
Forum Non Conveniens
1
Forum Selection
1
Genentech
1
Genzyme
1
Good Clinical Practices
1
Good Faith
1
Goodyear
1
Government Investigations
1
Health Information Technologies
1
Hedge Funds
1
Hoffman LaRoche
1
Home Healthcare Workers
1
HRSA
1
Imminent Harm
1
Implied Consent
1
Individual Mandate
1
Information Reports
1
Innovation Act
1
Integra
1
International Arbitration
1
Inventors
1
John Boehner
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Licensing Rules
1
Likelihood of Success
1
Lipitor
1
Long Arm Statute
1
Manufacturing Facilities
1
Marketing
1
Markman Hearing
1
Martin Shkreli
1
Mayo v. Prometheus
1
Meaningful Use
1
Means-Plus-Function
1
Medicaid Expansion
1
Medical Device Tax
1
Medical Foods
1
Mensing
1
Minimum Wage
1
Misbranding
1
Monopolization
1
Motion for Reconsideration
1
Motion to Transfer
1
New Trial
1
NIH
1
Nintendo
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Notice Requirements
1
Nunc Pro Tunc
1
Off-Label Use
1
Offsets
1
OTDP
1
Out-of-State Companies
1
Overpayment
1
PATENT Act
1
Patent Agent Privilege
1
Patent Dance
1
Patent Ownership
1
Patent Prosecution
1
Patent Reform
1
Patent Term Extensions
1
Patent Trolls
1
Patent-Misuse
1
Patient Safety
1
Pending Legislation
1
Personalized Medicine
1
Petition For Rehearing
1
Pharmacies
1
Physician Medicare Reimbursements
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Physicians
1
Policies and Procedures
1
Post-Grant Review
1
Presumption of Validity
1
Product Exclusivity
1
Proposed Regulation
1
Public Health Insurance Marketplace
1
Public Meetings
1
Rebates
1
Registration Requirement
1
Remand
1
Reporting Requirements
1
Research and Development
1
Research Tools
1
Restraining Orders
1
Restrictive Covenants
1
Risk Management
1
Risk-Based Approaches
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sanctions
1
SEC
1
Secretary of HHS
1
Section 337
1
Section 340B
1
Set-Asides
1
Sham Litigation Exception
1
Shire Development v Watson
1
SmithKline Beecham
1
SNDAs
1
Split of Authority
1
Standard Essential Patents
1
Standard of Proof
1
Startups
1
State Law Tort Claims
1
Subsidiaries
1
Suppliers
1
Tax Liability
1
The Common Rule
1
Tolling
1
Trade Secrets
1
Trademark Infringement
1
Trans-Pacific Partnership
1
Transfer of Title
1
Universal Health Services Inc v United States ex rel Escobar
1
Validity
1
Wage and Hour
1
Warning Labels
1
WIPO
1
Wyeth
1
Young Lawyers